Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation (original) (raw)

• Lipsitch, M. & Samore, M.H. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8, 347–354 (2002).
  Article PubMed PubMed Central Google Scholar
• Rice, L.B. Antimicrobial resistance in gram-positive bacteria. Am. J. Infect. Control 34 (suppl. 1), S11–19; discussion S64–73 (2006).
  Article PubMed Google Scholar
• Wright, A. et al. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000–2004. MMWR Morb. Mortal. Wkly. Rep. 55, 301–305 (2006).
  Google Scholar
• Payne, D.J., Gwynn, M.N., Holmes, D.J. & Pompliano, D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).
  Article PubMed CAS Google Scholar
• Talbot, G.H. et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42, 657–668 (2006).
  Article PubMed Google Scholar
• Jin, D.J. & Gross, C.A. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202, 45–58 (1988).
  Article PubMed CAS Google Scholar
• Drlica, K. & Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377–392 (1997).
  Article PubMed PubMed Central CAS Google Scholar
• Zhang, Y. & Young, D. Molecular genetics of drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 34, 313–319 (1994).
  Article PubMed CAS Google Scholar
• Woodford, N. & Ellington, M.J. The emergence of antibiotic resistance by mutation. Clin. Microbiol. Infect. 13, 5–18 (2007).
  Article PubMed CAS Google Scholar
• Miller, J.H. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annu. Rev. Microbiol. 50, 625–643 (1996).
  Article PubMed CAS Google Scholar
• Cirz, R.T. & Romesberg, F.E. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob. Agents Chemother. 50, 220–225 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• LeClerc, J.E., Li, B., Payne, W.L. & Cebula, T.A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208–1211 (1996).
  Article PubMed CAS Google Scholar
• Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1254 (2000).
  Article PubMed CAS Google Scholar
• Montanari, S. et al. Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Microbiology 153, 1445–1454 (2007).
  Article PubMed CAS Google Scholar
• Funchain, P. et al. The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness. Genetics 154, 959–970 (2000).
  PubMed PubMed Central CAS Google Scholar
• Giraud, A. et al. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291, 2606–2608 (2001).
  Article PubMed CAS Google Scholar
• Harris, R.S., Longerich, S. & Rosenberg, S.M. Recombination in adaptive mutation. Science 264, 258–260 (1994).
  Article PubMed CAS Google Scholar
• Cairns, J. & Foster, P.L. Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 128, 695–701 (1991).
  PubMed PubMed Central CAS Google Scholar
• Foster, P.L., Trimarchi, J.M. & Maurer, R.A. Two enzymes, both of which process recombination intermediates, have opposite effects on adaptive mutation in Escherichia coli. Genetics 142, 25–37 (1996).
  PubMed PubMed Central CAS Google Scholar
• Harris, R.S., Ross, K.J. & Rosenberg, S.M. Opposing roles of the holliday junction processing systems of Escherichia coli in recombination-dependent adaptive mutation. Genetics 142, 681–691 (1996).
  PubMed PubMed Central CAS Google Scholar
• McKenzie, G.J., Lombardo, M.J. & Rosenberg, S.M. Recombination-dependent mutation in Escherichia coli occurs in stationary phase. Genetics 149, 1163–1165 (1998).
  PubMed PubMed Central CAS Google Scholar
• McKenzie, G.J., Harris, R.S., Lee, P.L. & Rosenberg, S.M. The SOS response regulates adaptive mutation. Proc. Natl. Acad. Sci. USA 97, 6646–6651 (2000).
  Article PubMed CAS Google Scholar
• Cirz, R.T. et al. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3, e176 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Miller, C. et al. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305, 1629–1631 (2004).
  Article PubMed CAS Google Scholar
• Riesenfeld, C., Everett, M., Piddock, L.J. & Hall, B.G. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob. Agents Chemother. 41, 2059–2060 (1997).
  Article PubMed PubMed Central CAS Google Scholar
• Alonso, A., Campanario, E. & Martinez, J.L. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145, 2857–2862 (1999).
  Article PubMed CAS Google Scholar
• Boshoff, H.I., Reed, M.B., Barry, C.E. III & Mizrahi, V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113, 183–193 (2003).
  Article PubMed CAS Google Scholar
• Taddei, F. et al. Role of mutator alleles in adaptive evolution. Nature 387, 700–702 (1997).
  Article PubMed CAS Google Scholar
• Joo, L.M., Macfarlane-Smith, L.R. & Okeke, I.N. Error-prone DNA repair system in enteroaggregative Escherichia coli identified by subtractive hybridization. J. Bacteriol. 189, 3793–3803 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Bilello, J.A., Bauer, G., Dudley, M.N., Cole, G.A. & Drusano, G.L. Effect of 2′,3′-didehydro-3′-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob. Agents Chemother. 38, 1386–1391 (1994).
  Article PubMed PubMed Central CAS Google Scholar
• Paterson, D.L. & Bonomo, R.A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18, 657–686 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Weigel, L.M. et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569–1571 (2003).
  Article PubMed CAS Google Scholar
• Fosheim, G.E., Carey, R.B. & Limbago, B.M. Evaluation of the AdvanDx VRE EVIGENE assay for detection of vanA in vancomycin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45, 1611–1613 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Cao, T.B. & Saier, M.H. Jr. Conjugal type IV macromolecular transfer systems of Gram-negative bacteria: organismal distribution, structural constraints and evolutionary conclusions. Microbiology 147, 3201–3214 (2001).
  Article PubMed CAS Google Scholar
• Cascales, E. & Christie, P.J. Definition of a bacterial type IV secretion pathway for a DNA substrate. Science 304, 1170–1173 (2004).
  Article PubMed CAS Google Scholar
• Yeo, H.J. & Waksman, G. Unveiling molecular scaffolds of the type IV secretion system. J. Bacteriol. 186, 1919–1926 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Frost, L.S., Leplae, R., Summers, A.O. & Toussaint, A. Mobile genetic elements: the agents of open source evolution. Nat. Rev. Microbiol. 3, 722–732 (2005).
  Article PubMed CAS Google Scholar
• Hilleringmann, M. et al. Inhibitors of Helicobacter pylori ATPase Cagα block CagA transport and cag virulence. Microbiology 152, 2919–2930 (2006).
  Article PubMed CAS Google Scholar
• Backert, S. et al. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell. Microbiol. 2, 155–164 (2000).
  Article PubMed CAS Google Scholar
• Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497–1500 (2000).
  Article PubMed CAS Google Scholar
• Grohmann, E., Muth, G. & Espinosa, M. Conjugative plasmid transfer in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67, 277–301 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, I. & Dubnau, D. DNA uptake during bacterial transformation. Nat. Rev. Microbiol. 2, 241–249 (2004).
  Article PubMed CAS Google Scholar
• Fernandez-Lopez, R. et al. Unsaturated fatty acids are inhibitors of bacterial conjugation. Microbiology 151, 3517–3526 (2005).
  Article PubMed CAS Google Scholar
• Hurdle, J.G., O'Neill, A.J., Mody, L., Chopra, I. & Bradley, S.F. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J. Antimicrob. Chemother. 56, 1166–1168 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Beaber, J.W., Hochhut, B. & Waldor, M.K. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427, 72–74 (2004).
  Article PubMed CAS Google Scholar
• Moritz, E.M. & Hergenrother, P.J. Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc. Natl. Acad. Sci. USA 104, 311–316 (2007).
  Article PubMed CAS Google Scholar
• Engelberg-Kulka, H., Sat, B., Reches, M., Amitai, S. & Hazan, R. Bacterial programmed cell death systems as targets for antibiotics. Trends Microbiol. 12, 66–71 (2004).
  Article PubMed CAS Google Scholar
• Gerdes, K., Christensen, S.K. & Lobner-Olesen, A. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3, 371–382 (2005).
  Article PubMed CAS Google Scholar
• Gamage, S.D., Strasser, J.E., Chalk, C.L. & Weiss, A.A. Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin. Infect. Immun. 71, 3107–3115 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Fuchs, S. et al. Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb. Pathog. 27, 13–23 (1999).
  Article PubMed CAS Google Scholar
• Sumby, P. & Waldor, M.K. Transcription of the toxin genes present within the Staphylococcal phage φSa3ms is intimately linked with the phage's life cycle. J. Bacteriol. 185, 6841–6851 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Hastings, P.J., Rosenberg, S.M. & Slack, A. Antibiotic-induced lateral transfer of antibiotic resistance. Trends Microbiol. 12, 401–404 (2004).
  Article PubMed CAS Google Scholar
• Fish, D.N., Piscitelli, S.C. & Danziger, L.H. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15, 279–291 (1995).
  PubMed CAS Google Scholar
• Hobby, G.L., Meyer, K. & Chaffee, E. Observations on the mechanism of action of penicillin. Proc. Soc. Exp. Biol. Med. 50, 281–285 (1942).
  Article CAS Google Scholar
• Keren, I., Shah, D., Spoering, A., Kaldalu, N. & Lewis, K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186, 8172–8180 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Wiuff, C. et al. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49, 1483–1494 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Levin, B.R. & Rozen, D.E. Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4, 556–562 (2006).
  Article PubMed CAS Google Scholar
• Smith, A.L., Fiel, S.B., Mayer-Hamblett, N., Ramsey, B. & Burns, J.L. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123, 1495–1502 (2003).
  Article PubMed CAS Google Scholar
• Dworzack, D.L., Pugsley, M.P., Sanders, C.C. & Horowitz, E.A. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur. J. Clin. Microbiol. 6, 456–459 (1987).
  Article PubMed CAS Google Scholar
• Tuomanen, E., Durack, D.T. & Tomasz, A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30, 521–527 (1986).
  Article PubMed PubMed Central CAS Google Scholar
• Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5, 48–56 (2007).
  Article PubMed CAS Google Scholar
• Gilbert, P., Collier, P.J. & Brown, M.R. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 34, 1865–1868 (1990).
  Article PubMed PubMed Central CAS Google Scholar
• Rogers, H.J. The killing of bacteria by cell wall inhibitors. Contrib. Microbiol. Immunol. 1, 117–134 (1973).
  PubMed CAS Google Scholar
• Vazquez-Laslop, N., Lee, H. & Neyfakh, A.A. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188, 3494–3497 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Shah, D. et al. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6, 53 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Keren, I., Kaldalu, N., Spoering, A., Wang, Y. & Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230, 13–18 (2004).
  Article PubMed CAS Google Scholar
• Moyed, H.S. & Bertrand, K.P. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155, 768–775 (1983).
  Article PubMed PubMed Central CAS Google Scholar
• Falla, T.J. & Chopra, I. Stabilization of Rhizobium symbiosis plasmids. Microbiology 145, 515–516 (1999).
  Article PubMed CAS Google Scholar
• Buts, L., Lah, J., Dao-Thi, M.H., Wyns, L. & Loris, R. Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem. Sci. 30, 672–679 (2005).
  Article PubMed CAS Google Scholar
• Pedersen, K. et al. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 112, 131–140 (2003).
  Article PubMed CAS Google Scholar
• Christensen, S.K., Pedersen, K., Hansen, F.G. & Gerdes, K. Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 332, 809–819 (2003).
  Article PubMed CAS Google Scholar
• Pandey, D.P. & Gerdes, K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33, 966–976 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Pedersen, K., Christensen, S.K. & Gerdes, K. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45, 501–510 (2002).
  Article PubMed CAS Google Scholar
• Black, D.S., Irwin, B. & Moyed, H.S. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 176, 4081–4091 (1994).
  Article PubMed PubMed Central CAS Google Scholar
• Korch, S.B., Henderson, T.A. & Hill, T.M. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50, 1199–1213 (2003).
  Article PubMed CAS Google Scholar
• Li, Y. & Zhang, Y. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob. Agents Chemother. 51, 2092–2099 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Tsilibaris, V., Maenhaut-Michel, G., Mine, N. & Van Melderen, L. What is the benefit for E. coli to have multiple toxin-antitoxin systems in their genomes? J. Bacteriol., published online 18 May 2007 (doi:10.1128/JB.00527-07).
  Article PubMed PubMed Central CAS Google Scholar
• Korch, S.B. & Hill, T.M. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188, 3826–3836 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Correia, F.F. et al. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J. Bacteriol. 188, 8360–8367 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Spoering, A.L., Vulic, M. & Lewis, K. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188, 5136–5144 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Young, D., Hussell, T. & Dougan, G. Chronic bacterial infections: living with unwanted guests. Nat. Immunol. 3, 1026–1032 (2002).
  Article PubMed CAS Google Scholar
• Coates, A., Hu, Y., Bax, R. & Page, C. The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 1, 895–910 (2002).
  Article PubMed CAS Google Scholar
• Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16, 463–496 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Fritz, C., Maass, S., Kreft, A. & Bange, F.C. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect. Immun. 70, 286–291 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• McKinney, J.D. et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735–738 (2000).
  Article PubMed CAS Google Scholar
• Fang, F.C., Libby, S.J., Castor, M.E. & Fung, A.M. Isocitrate lyase (AceA) is required for Salmonella persistence but not for acute lethal infection in mice. Infect. Immun. 73, 2547–2549 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Palmer, K.L., Brown, S.A. & Whiteley, M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189, 4449–4455 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Cho, S.H. et al. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51, 1380–1385 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Smith, E.E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103, 8487–8492 (2006).
  Article PubMed CAS Google Scholar
• Mwangi, M.M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 104, 9451–9456 (2007).
  Article PubMed CAS Google Scholar
• Perez-Capilla, T. et al. SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J. Bacteriol. 187, 1515–1518 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Roy-Burman, A. et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183, 1767–1774 (2001).
  Article PubMed CAS Google Scholar
• Jain, M. et al. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J. Clin. Microbiol. 42, 5229–5237 (2004).
  Article PubMed PubMed Central Google Scholar
• Skinner, J.A., Pilione, M.R., Shen, H., Harvill, E.T. & Yuk, M.H. Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J. Immunol. 175, 4647–4652 (2005).
  Article PubMed CAS Google Scholar
• Troisfontaines, P. & Cornelis, G.R. Type III secretion: more systems than you think. Physiology (Bethesda) 20, 326–339 (2005).
  CAS Google Scholar
• Silver, L.L. Multi-targeting by monotherapeutic antibacterials. Nat. Rev. Drug Discov. 6, 41–55 (2007).
  Article PubMed CAS Google Scholar
• Gentry, D.R. et al. Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes. Antimicrob. Agents Chemother. 47, 1784–1789 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Heath, R.J. & Rock, C.O. A triclosan-resistant bacterial enzyme. Nature 406, 145–146 (2000).
  Article PubMed CAS Google Scholar
• Frank, A.C., Alsmark, C.M., Thollesson, M. & Andersson, S.G. Functional divergence and horizontal transfer of type IV secretion systems. Mol. Biol. Evol. 22, 1325–1336 (2005).
  Article PubMed CAS Google Scholar